Outset Medical, Inc.: AQR CAPITAL MANAGEMENT LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
AQR Capital Management amended its Schedule 13G filing on Outset Medical, Inc., disclosing its updated passive stake in the medical device maker via SEC accession 0001167557-26-000250. The filing reflects AQR's current holdings and any change from its prior reported position, though the headline disclosure did not specify the exact share count or percentage. Schedule 13G amendments are typically filed when a passive investor's ownership crosses or adjusts around the 5% reporting threshold, making the update a signal of institutional positioning in Outset. Investors will watch for the detailed filing to confirm AQR's precise stake and whether the change reflects accumulation or trimming.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Outset Medical, Inc., AQR Capital Management LLC